Although it is becoming increasingly evident that nitric oxide (NO) mediates some of estrogen's actions in the brain, the effects of estrogen on NO production through NO synthases (NOS) in neuronal cells have not yet been identified. Here we assessed changes in NO production induced by 17␤-estradiol (E2) in cells of neuronal origin using human SK-N-SH neuroblastoma cells, which we show express all three isoforms of NOS. Involvement of NOS isoforms in E2-induced NO production was examined using isoform-specific NOS inhibitors. E2 (10 
, modulation of autonomic functions (2-4), neuroprotective effects (5) , and improvement on cognitive tasks (6) . Many of these effects are mediated or influenced by nitric oxide (NO), a highly reactive gaseous mediator involved in many physiological processes in the brain (7) (8) (9) . Treatment with 17␤-estradiol (E2) has been shown to increase NO synthase (NOS) expression and numbers of NO-producing neurons in several regions of the brain (10, 11) , and neuronal NOS (nNOS) expression is regulated by estrogen receptor-␣ (ER␣) in both male and female brains (12) . In cultured hippocampal neurons, NO mediates E2-induced neurite production (13) . In vivo, we recently demonstrated that E2 attenuates blood pressure responses to psychological stress in ovariectomized rats and that these effects are mediated by NO in the brain (4) . Together these studies suggest that NO may play an important role in mediation of estrogen's effects in neuronal tissues.
NO is catalytically generated by a family of NOSs, including two constitutive Ca 2ϩ /calmodulin-dependent isoforms (cNOS), namely nNOS (NOS1) and endothelial NOS (eNOS; NOS3), and one Ca 2ϩ /calmodulin-independent isoform, inducible NOS (iNOS; NOS2). The expression of NOS isoforms is related to tissue and cell types. For example, eNOS is widely distributed in the cardiovascular system, including cerebrovascular tissues, where NO production occurs via activation of eNOS in endothelial cells (14, 15) . nNOS is distributed throughout the central nervous system, where its activity contributes to NO production in neuronal cells (12, 16, 17) . iNOS is expressed mainly in activated immune cells, including microglia in the brain (18) , and is not usually expressed in neurons. However, increasing evidence has demonstrated that in addition to nNOS, both eNOS and iNOS are present or can be induced in neuronal cells. eNOS has been found in hippocampal neurons (19) , motor neurons (20) , and neuroblastoma cells (21) ; the expression of iNOS has also been found in neuroblastoma cells (21) and can be activated in neuronal cells by inflammation, injury, or ischemia (22, 23) . Thus, these studies suggest that the presence of eNOS and iNOS in neuronal tissues cannot be ignored, and that the expression and activation of NOS isoforms depend on cell responses to different challenges.
Although it has been shown that estrogen affects NO production through genomic and/or nongenomic actions (12, 17, 24, 25) , little information is available about how this steroid hormone influences NO synthesis in neuronal cells, because most studies to date have been carried out using Abbreviations: BAPTA-AM, 1,2-Bis(2-aminophenoxy)ethane-N,N,NЈ,NЈ-tetraacetic acid acetoxymethyl ester; cNOS, constitutive nitric oxide synthase; DAN, 2,3-diaminonaphtalene; E2, 17␤-estradiol; eNOS, endothelial nitric oxide synthase; ER, estrogen receptor; IC 50 , 50% inhibitory concentration; iNOS, inducible nitric oxide synthase; l-NIO, N 5 -(1-Iminoethyl)-l-ornithine; NF-B, nuclear factor-B; nNOS, neuronal nitric oxide synthase; NO, nitric oxide; NOS, nitric oxide synthase; vinyl-l-NIO,
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endothelial cells or other cells of nonneuronal origin. In the present study we assessed the effects of estrogen on NO production in SK-N-SH human neuroblastoma cells, a model widely used to study the effects of estrogen in neuronal cells (26 -28) . To characterize the effects of estrogen on NO production, SK-N-SH cells were treated with various concentrations of E2, and the time course of NO release was evaluated using a physiological concentration of E2. Ca 2ϩ -free medium, nifedipine, an L-type Ca 2ϩ channel blocker, or 1,2-bis(2-aminophenoxy)ethane-N,N,NЈ,NЈ-tetraacetic acid acetoxymethyl ester (BAPTA/AM), an intracellular Ca 2ϩ chelator, were used to determine whether E2-induced NO production is Ca 2ϩ dependent. Immunoblot analysis was applied to examine whether the different NOS isoforms are expressed in SK-N-SH cells. Finally, we used isoformspecific NOS inhibitors to identify which NOS isoform(s) contributes to E2-induced NO production.
Materials and Methods Materials
Human SK-N-SH neuroblastoma cells were obtained from American Type Culture Collection (Manassas, VA). All reagents for cell culture were purchased from Invitrogen Life Technologies (Burlington, Canada) unless otherwise stated. E2, nifedipine, BAPTA/AM, and 1400W were purchased from Sigma-Aldrich Corp. (Oakville, Canada). Vinyl-l-NIO was purchased from Alexis (San Diego, CA), ICI 182,780 and l-NIO were obtained from Tocris (Ellisville, MO), and 2,3-diaminonaphtalene (DAN) was purchased from Molecular Probes (Eugene, OR).
Cell culture
SK-N-SH cells were cultured in Eagle's MEM containing 10% fetal bovine serum, 2 mm l-glutamine, 0.1 mm MEM nonessential amino acids, 1 mm sodium pyruvate, 100 U/ml penicillin G, and 100 g/ml streptomycin in a humidified incubator with 5% CO 2 in air at 37 C. Medium was changed every 2-3 d. Subconfluent cells were harvested and seeded at a density of 1 ϫ 10 5 cells/well in six-well culture plates with phenol red-free MEM containing 5% charcoal/dextran-stripped fetal bovine serum. At 48 h after plating, cells were washed twice with serum-free medium and treated with drugs or vehicle in serum-free medium for different periods according to the experimental design.
Nitrite assay
NO production was determined by measuring nitrite accumulation in culture medium using a modified fluorometric assay (29) with DAN. Briefly, cells cultured in six-well plates were washed twice with phenol red-free and serum-free MEM, 1.2 ml of the same medium containing vehicle or drugs were added to each well, and cells were incubated for the time period designated. In some experiments, Ca 2ϩ -free Hanks' medium was used in place of MEM to study the role of extracellular Ca 2ϩ . After incubation, 500 l medium were removed from each well and mixed with freshly prepared 40 l DAN (50 g/ml) in 0.62 m HCl, then incubated for 15 min at room temperature. The reaction was terminated by the addition of 50 l 2.8 m NaOH. Fluorescence was measured using a spectrofluorometer (SLM-Aminco, model 8100, SLM Instruments, Inc., Rochester, NY), with excitation and emission wavelengths set at 365 and 450 nm, respectively. The amount of nitrite in the sample was calculated according to a standard curve prepared with sodium nitrite.
NOS activity
NOS activity in cell lysates was determined by measuring [ 3 H]larginine conversion to [ 3 H]l-citrulline using an NOS assay kit (Calbiochem, San Diego, CA). Briefly, harvested cells were homogenized in buffer [25 mm Tris-HCl (pH 7.4), 1 mm EDTA, and 1 mm EGTA], and protein concentrations of cell homogenates were determined with the Bradford method using protein assay reagents (Bio-Rad Laboratories, Hercules, CA). Equal quantities of cell proteins (5 g) were incubated with [
3 H]l-arginine (1 Ci/l, 64 Ci/mmol; Amersham Biosciences, Piscataway, NJ) in reaction buffer containing 1 mm NADPH and 0.6 mm CaCl 2 for 30 min at room temperature. Changes in NOS activities were determined in the presence or absence of selective compounds.
Protein preparation and immunoblot analysis
Cells were harvested and homogenized with lysis buffer [0.01 m PBS (pH 7.4), 0.1% tergitol, 0.5% sodium deoxycholate, 0.1% sodium dodecyl sulfate, 0.5 mm sodium orthovanadate, 0.1 mg/ml phenylmethylsulfonylfluoride, and 10 g/ml aprotinin) and quantified for protein concentrations as described above. Proteins in homogenates were separated by electrophoresis on 8% sodium dodecyl sulfate-polyacrylamide gels and transferred to nitrocellulose membrane. The membranes were blocked overnight with 5% nonfat dry milk in Tris-buffered saline (20 mm Tris-HCl, 150 mm NaCl, and 0.05% Tween 20) at 4 C, followed by incubation for 1 h with a primary antibody at room temperature. Rabbit polyclonal antihuman eNOS (sc-654, Santa Cruz Biotechnology, Inc., Santa Cruz, CA) was used at a dilution of 1:1000, and rabbit polyclonal antihuman nNOS (AB5380, Chemicon International, Temecula, CA) was used at a dilution of 1:2000. Mouse monoclonal anti-iNOS (sc7271, Santa Cruz Biotechnology, Inc.) was used at a dilution of 1:500. A horseradish peroxidase-conjugated goat antirabbit IgG (Jackson ImmunoResearch Laboratories, Mississauga, Canada) or rabbit antimouse IgG (SigmaAldrich Corp., St. Louis, MO) was used as a secondary antibody (1:5000). For internal controls, membranes were stripped and probed with monoclonal anti-␤-actin (Sigma-Aldrich Corp.) at a dilution of 1:5000. Immunocomplexes were detected with the enhanced chemiluminescence kit (Amersham Biosciences) and autoradiography film. The levels of proteins were imaged and quantified using the VersaDoc Imaging System (model 3000) with Quantity One software (Bio-Rad Laboratories).
Experimental design
To determine the effects of estrogen on NO production, cells were incubated with varying concentrations of E2, ranging from 0.1-1000 nm, and nitrite levels in the medium were examined 30 min after treatment. The time course of changes in nitrite levels was assessed 5, 15, 30, 60, and 120 min after treatment of E2 (10 nm). To examine whether different NOS isoforms are expressed in SK-N-SH cells and to assess acute effects of estrogen on NOS expression, immunoblot analyses were performed after cells were treated for 1 h (unless otherwise stated) in the presence or the absence of E2 (0.1-1000 nm).
The following two approaches were used to study the involvement of ERs and NOS in the effects of 10 nm E2 on NO production. 1) Cells were preincubated with medium containing an ER antagonist or NOS inhibitor for 15 min; medium was then replaced with E2 plus the inhibitor for 30 min. 2) Cells were treated for 30 min with E2 in the presence or absence of an ER antagonist or NOS inhibitor, and nitrite levels in the medium and NOS activities in cell extracts were measured thereafter. To evaluate whether the E2-induced NO release is mediated via ERs, we used ICI 182,780, an antagonist of ERs. To identify the NOS isoforms that are responsible for the E2-induced NO production, vinyl-l-NIO, l-NIO, and 1400W were used. The 50% inhibitory concentration (IC 50 ) values of vinyl-l-NIO for nNOS, eNOS, and iNOS are approximately 0.1, 12, and 60 m, making it 120-and 600-fold more selective for nNOS than for eNOS or iNOS, respectively (30) . Although highly selective eNOS inhibitors are not currently available, l-NIO has been reported to inhibit eNOS (IC 50 ϭ 0.5 m) with 8-and 4-fold more selectivity than nNOS and iNOS, respectively (31) . 1400W has been shown to be 31-fold more selective for iNOS (IC 50 ϭ 0.23 m) than nNOS and more than 4000-fold more selective than for eNOS (32) .
To evaluate the role of extracellular Ca 2ϩ in E2-induced NO responses, incubations were carried out in Ca 2ϩ -free medium or in the presence of nifedipine, an L-type Ca 2ϩ channel blocker. To determine whether intracellular Ca 2ϩ plays a role, cells were treated with E2 in the presence or absence of BAPTA/AM, an intracellular Ca 2ϩ chelator.
Statistical analysis
Data are presented as the mean Ϯ sem of four to six wells from at least three independent experiments. Depending on the experiment, differ-ences among groups were determined by one-or two-way ANOVA, followed by the post hoc Student-Newman-Keuls test. Values of P Ͻ 0.05 were considered statistically significant.
Results

Characteristics of E2-induced NO production
The dose-response effects of E2 on NO production in SK-N-SH cells are shown in Fig. 1A . After 30 min of treatment with E2 at 0.1-1000 nm, nitrite levels in the medium were increased, with the largest increase occurring with 10 nm E2. We thus used E2 at 10 nm to evaluate the time course of NO release. A significant increase in nitrite levels was observed 5 min after E2 treatment (Fig. 1B) . Levels continued to rise until 1 h and were significantly higher than control values.
Effects of ICI 182,780
The potential role of ERs in E2-induced NO production was assessed using ICI 182,780 at 1 or 10 m. These doses of ICI 182,780 have been shown to block E2-induced NO production and NOS activity in endothelial cells (33, 34) . ICI 182,780 at 1 m decreased the E2-induced increases in nitrite levels by 66%, and ICI 182,780 at 10 m completely inhibited the response (Fig. 2) , indicating that stimulation of NO production in SK-N-SH cells is an ER-mediated event.
Expression of NOS isoforms
Expression of nNOS, eNOS, and iNOS was detectable in SK-N-SH cells, although the expression level for iNOS was relatively low (Fig. 3) . Increases in eNOS protein levels of approximately 30% were found 1 h after treatment with E2 at low concentrations (0.1 and 1 nm), whereas levels of eNOS proteins were decreased by approximately 16% at high concentrations of E2 (1 m; Fig. 3A) . Similar results were obtained when immunoblots were performed 30 min after E2 treatment (data not shown). E2-induced changes in eNOS protein levels were inhibited by 0.1-1000 nm ICI 182,780 (Fig.  3A) . Treatment of cells with E2 did not change the expression of nNOS or iNOS (Fig. 3, B and C) . These results suggest that E2 induces rapid changes in eNOS protein levels through its receptors.
Identification of NOS isoforms by NOS inhibitors
Vinyl-l-NIO (a highly selective nNOS inhibitor) and l-NIO (an eNOS inhibitor) were used to determine whether constitutive NOS's are responsible for E2-induced NO production. E2-induced increases in nitrite levels were inhibited by 92% with 1 m vinyl-l-NIO and were completely inhibited with 100 m vinyl-l-NIO (Fig. 4A) . Vinyl-l-NIO also inhibited E2-induced increases in NOS activity (Fig. 5) . Sim- ilarly, the addition of l-NIO (1 or 5 m) prevented E2-induced increases in nitrite levels (Fig. 4B ) and NOS activities (Fig. 5) . These results suggest that nNOS and eNOS are both involved in E2-induced NO production in SK-N-SH cells.
To determine whether iNOS activity is involved in E2-induced NO production, 1400W, a highly selective iNOS inhibitor, was used at 5 m, a dose previously shown to completely inhibit cytokine-induced NO production in cultured cells (35) . In contrast to vinyl-l-NIO and l-NIO, 1400W had no significant effects on E2-induced increases in nitrite levels (Fig. 4B) or NOS activity (Fig. 5) , suggesting that iNOS activity does not contribute to E2-induced NO production.
Role of Ca 2ϩ
To verify that E2-induced NO production is mediated by constitutive NOSs, we determined the role of Ca 2ϩ in the NO
FIG. 3. Expression of NOS isoforms in SK-N-SH cell extracts. Cells
were treated for 60 min in the presence or absence of E2 (0.1-1000 nM) with or without equal concentrations of ICI 182,780 (0.1-1000 nM), and samples prepared from cell extracts were analyzed on immunoblots using antibodies against eNOS, nNOS, and iNOS. A, Effects of E2 on eNOS proteins. eNOS was detected at 145 kDa. * or #, P Ͻ 0.05 vs. vehicle control. B, Effects of E2 on nNOS. Three nNOS splice variants, including nNOS-, nNOS-␣, and nNOS-2, were detected at 165, 160, and 144 kDa, respectively. C, Effects of E2 on iNOS. iNOS was detected at 130 kDa. response. When Ca 2ϩ -free medium was used, basal NO levels were inhibited by 25%, and the addition of E2 (10 nm) did not induce increases in nitrite levels (Fig. 6A) . Similarly, basal NO levels were inhibited by 8% with nifedipine (1 m) in Ca 2ϩ -containing medium, and E2 did not increase nitrite levels in the presence of nifedipine (Fig. 6B) . Finally, the addition of BAPTA/AM (50 m) inhibited E2-induced nitrite production by approximately 56% (Fig. 7A) . These results suggest that both intra-and extracellular Ca 2ϩ influences E2-induced NO production.
BAPTA/AM-induced NO release
Cells treated with BAPTA/AM alone showed an increase in nitrite production compared with vehicle-treated controls (Fig. 7B) . To determine whether BAPTA/AM-induced nitrite production involves activation of iNOS, 1400W (5 m) was applied. Compared with BAPTA/AM alone, a significant drop in nitrite levels was observed after treatment with BAPTA/AM plus 1400W (Fig. 7C) , indicating that iNOS activity is involved in BAPTA/AM-induced nitrite production.
Discussion
The data presented in this study demonstrate that estrogen at concentrations in the physiological range stimulates NO release in human neuroblastoma cells. This response occurs rapidly and can be blocked with ICI 182,780. The response is also inhibited with BAPTA/AM, upon removal of Ca 2ϩ from the medium, and after the addition of nifedipine. These results suggest that E2-induced NO production in neuroblastoma cells involves ER receptor-mediated and Ca 2ϩ -sensitive events. Furthermore, we show that nNOS, eNOS, and iNOS are expressed in SK-N-SH cells, in agreement with a previous study that showed that SK-N-MC neuroblastoma cells express these NOS isoforms (21) . Expression of the different NOS isoforms in these neuroblastoma cells allowed us to determine whether E2-induced NO production involves selective activation of an NOS isoform(s). Using specific NOS inhibitors, we show that E2 stimulates the production of NO in SK-N-SH cells through activation of the cNOS isoforms, eNOS and nNOS.
One of the challenges in demonstrating the involvement of individual NOS isoforms in E2-induced NO production is that no highly selective eNOS inhibitors are currently available. Although the finding that l-NIO inhibited E2-induced NO production supports the involvement of eNOS, we can- not exclude the possibility that nNOS activity may have been slightly affected by l-NIO, because the degree of selectivity of l-NIO for eNOS over nNOS is not large. In contrast, vinyl-l-NIO at 1 m effectively inhibits nNOS (36), but does not appreciably affect eNOS activity (30) . Thus, our finding that 1 m vinyl-l-NIO did not completely inhibit estrogeninduced NO release supports our contention that in addition to nNOS, eNOS is involved in the effects of E2. In contrast to l-NIO and vinyl-l-NIO, 1400W had no effect on the E2-induced NO release. These data, taken together, suggest that the induction of NO production by estrogen occurs via activation of the two cNOSs, nNOS and eNOS, but not via iNOS. These findings are consistent with our recent in vivo study that showed that estrogen replacement in ovariectomized female rats modulates cardiovascular responses to psychological stress through NO release in the brain via activation of cNOS (4) . Thus, by showing that estrogen stimulates NO release through cNOS activities, our data contribute to the fundamental understanding of estrogen's actions on NO production in neuronal cells.
The finding that E2-induced NO production occurs through activation of cNOS is also supported by our data obtained using Ca 2ϩ blockers; removal of Ca 2ϩ from the medium or addition of nifedipine decreased the basal level of NO release and prevented an increase in NO production induced by E2. These results suggest that extracellular Ca 2ϩ is critical to the maintenance of basal levels of NO production in neuroblastoma cells. We also demonstrate that BAPTA/AM inhibits E2-induced NO production, supporting the idea that intracellular Ca 2ϩ is required in E2-induced activation of cNOS. Consistent with our results, previous studies have shown that an E2-induced transient rise in the intracellular Ca 2ϩ concentration is followed by NO release in monocytes (37) ; an increase in eNOS phosphorylation was more pronounced in the presence of ionomycin, a Ca 2ϩ -mobilizing agent, in uterine artery endothelial cells (38) . The mobilization of Ca 2ϩ by estrogen is mediated through membrane ERs (37, 38) , but the source of the Ca 2ϩ may differ among cell types, because increases in intracellular Ca 2ϩ occurred through activation of L-type, voltage-gated Ca 2ϩ channels in female colonic epithelium (39) , whereas Ca 2ϩ was released from intracellular Ca 2ϩ stores in astrocytes (40) . The mechanism by which estrogen causes activation of cNOS in neuronal tissues is unclear. Previous studies have indicated that E2 may act through several different pathways, including ER-mediated genomic and nongenomic pathways and non-ER-mediated, nongenomic pathways (41) (42) (43) . In endothelial cells, a rapid increase in E2-induced NO production occurred through activation of eNOS, which required the ER␣ ligand-binding domain, but did not require the hormone's nuclear effects (44) , and could be blocked by ICI 182,780 (44, 45) . In mollusk pedal ganglia, acute NO release induced by E2 has been reported to act through an ER␤ expressed on the cell surface (46) . These data suggest that the effects of estrogen on NO production involve an ER-mediated, nongenomic pathway. Similarly, we show that stimulation of NO release in neuroblastoma cells by E2 occurs as early as 5 min after exposure to E2, that this response is Ca 2ϩ dependent, and that it could be blocked by ICI 182,780. These results suggest that the acute effects of estrogen on NO release in neuroblastoma cells probably involve an ER-mediated and Ca 2ϩ -dependent nongenomic pathway. Finally, we also demonstrate that changes in levels of eNOS protein occur as early as 30 min after the addition of E2, consistent with the observation that E2 stimulates eNOS internalization, which occurs immediately after enzyme activation and is blocked by ICI 182,780 in endothelial cells (47) . Moreover, translocation of eNOS from the lipid-anchored membrane to the cytoplasm increases enzyme phosphorylation and solubilization (48, 49) . Thus, it is likely that acute changes in eNOS proteins induced by E2 involve posttranslational modifications, including protein-protein interactions and subsequent induction of eNOS subcellular trafficking, recycling, and degradation (49 -51) .
It is worth noting that BAPTA/AM, an intracellular Ca 2ϩ chelator, did not completely inhibit E2-induced NO production even at a relatively high concentration (50 m). The reason for this response is probably that BAPTA/AM itself stimulated an increase in NO release through activation of iNOS, because the response could be blocked by 1400W. This result is consistent with the idea that iNOS activity is Ca 2ϩ independent. Because activation of iNOS in neuronal tissues is correlated with incidence of tissue injury and damage, our finding that NO levels are augmented by BAPTA/AM via activation of iNOS may explain the toxic effects of BAPTA/AM described by other investigators (52, 53) . Unlike a large increase in NO release induced by tissue injury and inflammation, we show that E2-induced enhancement in NO levels is relatively small, supporting the idea that changes in NO production are stimulus dependent. Furthermore, increasing concentrations of E2 do not stimulate greater release of NO. Although the reason for this phenomenon is not known at this time, it is possible that the ERs required for NO production from cNOS are fully occupied at the lower concentrations of E2.
Estrogen has been shown to exert an important neuroprotective effect (43, 54) , which has been suggested to be mediated by cNOS-derived NO release (55) and its related cGMP-dependent protein kinase pathway (56) . This hypothesis is based on the observation that basal levels of NO produced by cNOS provide a protective effect in neural tissues through suppression of nuclear factor-B (NF-B) and subsequent inhibition of relevant immune responses. In contrast, ␤-amyloid, a major constituent of senile plaques in Alzheimer's disease, has been shown to decrease basal NO levels by inhibiting cNOS activities (57) , but to increase iNOS activity through activation of TNF␣ and NF-B signaling pathways (58) . We now show that E2 induces NO production through activation of cNOS, rather than iNOS, in neuron-like cells, supporting the idea that activation of cNOS may contribute to estrogen's neuroprotective effects.
In summary, we have shown for the first time that concentrations of E2 in the physiological range cause rapid increases in NO production in neuroblastoma cells through activation of cNOS, but not iNOS. By demonstrating that nNOS and eNOS both contribute to E2-induced NO synthesis in cells of neuronal origin, our results bring into question the common assumption that estrogen affects NO release in neuronal cells only through nNOS activation. We also demonstrate that the rapid effects of estrogen on NO and eNOS proteins occur through membrane-mediated nongenomic events, rather than classic genomic pathways. In addition, we have shown that BAPTA/AM stimulates NO release in neuroblastoma cells through activation of iNOS, suggesting that differential activation of NOS isoforms can occur in response to different treatments in the same cells. This finding is important, because activation of different NOS isoforms leads to production of different levels of NO, which, in turn, can exert either beneficial or pathological effects in cells and tissues. Finally, we have already shown in vivo that estrogen's actions on blood pressure responses to psychological stress are mediated by NO in the brain (4) . Although it is important to emphasize that our current results in neuroblastoma cells do not necessarily translate directly to responses in vivo, the present study provides new insight into the possible mechanisms for interactions between estrogen and NO in neuronal cells.
